Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination

Journal of the Neurological Sciences

Volumn 333, Issue 1-2, 2013, Pages 76-87

  Rostami, Abdolmohamad ^a   Ciric, Bogoljub ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

T cell; EAE; GM CSF; IL 23; IL 27; Multiple sclerosis; Th1; Th17; Th9; Treg

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 9;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; EXPERIMENTAL MODEL; GAMMA DELTA T LYMPHOCYTE; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANTIGEN PRESENTING CELLS; APC; CENTRAL NERVOUS SYSTEM; CNS; EAE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GM-CSF; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR; IFN; IL; IL-23; IL-27; INTERFERON; INTERLEUKIN; MBP; MOG; MS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; NO; REGULATORY T CELLS; TH1; TH17; TH9; TNF; TREG; TREGS; TUMOR NECROSIS FACTOR; WILD-TYPE; WT; ΓΔ T CELL;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84884907926     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.03.002     Document Type: Article

References (207)

1. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N Engl J Med 343 13 2000 938 952 [Epub 2000/09/28]
2. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N Engl J Med 354 9 2006 942 955 [Epub 2006/03/03]
3. A. Nylander, and D.A. Hafler Multiple sclerosis J Clin Invest 122 4 2012 1180 1188 [Epub 2012/04/03]
4. L. Steinman, and S.S. Zamvil How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis Ann Neurol 60 1 2006 12 21 [Epub 2006/06/28]
5. V.K. Kuchroo, A.C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L.B. Nicholson T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire Annu Rev Immunol 20 2002 101 123 [Epub 2002/02/28]
6. R. Furlan, C. Cuomo, and G. Martino Animal models of multiple sclerosis Methods Mol Biol 549 2009 157 173 [Epub 2009/04/21]
7. K.C. Williams, E. Ulvestad, and W.F. Hickey Immunology of multiple sclerosis Clin Neurosci 2 3,4 1994 229 245 [Epub 1994/01/01]
8. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136 7 1986 2348 2357 [Epub 1986/04/01]
9. T.L. Stevens, A. Bossie, V.M. Sanders, R. Fernandez-Botran, R.L. Coffman, and T.R. Mosmann Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells Nature 334 6179 1988 255 258 [Epub 1988/07/21]
10. D.G. Ando, J. Clayton, D. Kono, J.L. Urban, and E.E. Sercarz Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype Cell Immunol 124 1 1989 132 143 [Epub 1989/11/01]
11. R.R. Voskuhl, R. Martin, C. Bergman, M. Dalal, N.H. Ruddle, and H.F. McFarland T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes Autoimmunity 15 2 1993 137 143 [Epub 1993/01/01]
12. R.C. van der Veen, J.A. Kapp, and J.L. Trotter Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells J Neuroimmunol 48 2 1993 221 226 [Epub 1993/11/01]
13. K. Markiewicz, M. Cholewa, and M. Luciak Influence of tobacco smoking on serum free fatty acid, triglyceride and glucose levels during physical training and post-exertional restitution Acta Med Acad Sci Hung 35 3,4 1978 225 232 [Epub 1978/01/01]
14. T. Olsson Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis Immunol Rev 144 1995 245 268 [Epub 1995/04/01]
15. E. Pierson, S.B. Simmons, L. Castelli, and J.M. Goverman Mechanisms regulating regional localization of inflammation during CNS autoimmunity Immunol Rev 248 1 2012 205 215 [Epub 2012/06/26]
16. U. Traugott, and P. Lebon Multiple sclerosis: involvement of interferons in lesion pathogenesis Ann Neurol 24 2 1988 243 251 [Epub 1988/08/01]
17. P. Chomarat, M.C. Rissoan, J. Banchereau, and P. Miossec Interferon gamma inhibits interleukin 10 production by monocytes J Exp Med 177 2 1993 523 527 [Epub 1993/02/01]
18. G. Trinchieri Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma) Curr Opin Immunol 9 1 1997 17 23 [Epub 1997/02/01]
19. H.S. Panitch, R.L. Hirsch, J. Schindler, and K.P. Johnson Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system Neurology 37 7 1987 1097 1102 [Epub 1987/07/01]
20. T. Chitnis, N. Najafian, C. Benou, A.D. Salama, M.J. Grusby, and M.H. Sayegh Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis J Clin Invest 108 5 2001 739 747 [Epub 2001/09/07]
21. N.G. Jacobson, S.J. Szabo, R.M. Weber-Nordt, Z. Zhong, R.D. Schreiber, and J.E. Darnell Jr. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 J Exp Med 18 5 1995 1755 1762 [Epub 1995/05/01]
22. E. Bettelli, B. Sullivan, S.J. Szabo, R.A. Sobel, L.H. Glimcher, and V.K. Kuchroo Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis J Exp Med 200 1 2004 79 87 [Epub 2004/07/09]
23. B. Gran, G.X. Zhang, S. Yu, J. Li, X.H. Chen, and E.S. Ventura IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination J Immunol 169 12 2002 7104 7110 [Epub 2002/12/10]
24. M. Krakowski, and T. Owens Interferon-gamma confers resistance to experimental allergic encephalomyelitis Eur J Immunol 26 7 1996 1641 1646 [Epub 1996/07/01]
25. E.H. Tran, E.N. Prince, and T. Owens IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines J Immunol 164 5 2000 2759 2768 [Epub 2000/02/29]
26. G.X. Zhang, B. Gran, S. Yu, J. Li, I. Siglienti, and X. Chen Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system J Immunol 170 4 2003 2153 2160 [Epub 2003/02/08]
27. T.T. Duong, F.D. Finkelman, B. Singh, and G.H. Strejan Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains J Neuroimmunol 53 1 1994 101 107 [Epub 1994/08/01]
28. T.T. Duong, J. St Louis, J.J. Gilbert, F.D. Finkelman, and G.H. Strejan Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse J Neuroimmunol 36 2,3 1992 105 115 [Epub 1992/02/01]
29. H. Heremans, C. Dillen, M. Groenen, E. Martens, and A. Billiau Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma Eur J Immunol 26 10 1996 2393 2398 [Epub 1996/10/01]
30. I.A. Ferber, S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, and L. Steinman Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE) J Immunol 156 1 1996 5 7 [Epub 1996/01/01]
31. D.O. Willenborg, S. Fordham, C.C. Bernard, W.B. Cowden, and I.A. Ramshaw IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis J Immunol 157 8 1996 3223 3227 [Epub 1996/10/15]
32. D.O. Willenborg, S.A. Fordham, M.A. Staykova, I.A. Ramshaw, and W.B. Cowden IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide J Immunol 163 10 1999 5278 5286 [Epub 1999/11/24]
33. G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity Annu Rev Immunol 13 1995 251 276 [Epub 1995/01/01]
34. R.A. Seder, R. Gazzinelli, A. Sher, and W.E. Paul Interleukin 12 acts directly on CD4 + T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming Proc Natl Acad Sci U S A 90 21 1993 10188 10192 [Epub 1993/11/01]
35. J.P. Leonard, K.E. Waldburger, and S.J. Goldman Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 J Exp Med 181 1 1995 381 386 [Epub 1995/01/01]
36. J.J. Bright, C. Du, M. Coon, S. Sriram, and S.J. Klaus Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline J Immunol 161 12 1998 7015 7022 [Epub 1998/12/23]
37. H. Heremans, C. Dillen, M. Groenen, P. Matthys, and A. Billiau Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice Eur Cytokine Netw 10 2 1999 171 180 [Epub 1999/07/10]
38. M. Ichikawa, C.S. Koh, A. Inoue, J. Tsuyusaki, M. Yamazaki, and Y. Inaba Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing-remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide J Neuroimmunol 102 1 2000 56 66 [Epub 2000/01/08]
39. E.M. Shevach, J.T. Chang, and B.M. Segal The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells Springer Semin Immunopathol 21 3 1999 249 262 [Epub 2000/02/10]
40. B. Becher, B.G. Durell, and R.J. Noelle Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 J Clin Invest 110 4 2002 493 497 [Epub 2002/08/22]
41. J.P. Leonard, K.E. Waldburger, R.G. Schaub, T. Smith, A.K. Hewson, and M.L. Cuzner Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12 Crit Rev Immunol 17 5,6 1997 545 553 [Epub 1997/01/01]
42. B. Gran, N. Chu, G.X. Zhang, S. Yu, Y. Li, and X.H. Chen Early administration of IL-12 suppresses EAE through induction of interferon-gamma J Neuroimmunol 156 1,2 2004 123 131 [Epub 2004/10/07]
43. X. Cheng, Z. Zhao, E. Ventura, B. Gran, K.S. Shindler, and A. Rostami The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma J Neuroimmunol 185 1,2 2007 75 86 [Epub 2007/02/27]
44. N. Berghmans, C. Dillen, and H. Heremans Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way J Neuroimmunol 176 1,2 2006 63 75 [Epub 2006/06/13]
45. Y. Jee, and Y. Matsumoto Two-step activation of T cells, clonal expansion and subsequent Th1 cytokine production, is essential for the development of clinical autoimmune encephalomyelitis Eur J Immunol 31 6 2001 1800 1812 [Epub 2001/06/01]
46. C.S. Constantinescu, B. Hilliard, M. Wysocka, E.S. Ventura, M.K. Bhopale, and G. Trinchieri IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE) J Neurol Sci 171 1 1999 60 64 [Epub 1999/11/24]
47. Z. Ahmed, D. Baker, and M.L. Cuzner Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat J Neuroimmunol 140 1,2 2003 109 117 [Epub 2003/07/17]
48. C.S. Constantinescu, K. Frei, M. Wysocka, G. Trinchieri, U. Malipiero, and A. Rostami Astrocytes and microglia produce interleukin-12 p40 Ann N Y Acad Sci 795 1996 328 333 [Epub 1996/10/31]
49. C.S. Constantinescu, M. Wysocka, B. Hilliard, E.S. Ventura, E. Lavi, and G. Trinchieri Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis J Immunol 161 9 1998 5097 5104 [Epub 1998/10/30]
50. C.S. Constantinescu, B. Hilliard, E. Ventura, M. Wysocka, L. Showe, and E. Lavi Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively Clin Immunol 98 1 2001 23 30 [Epub 2001/01/06]
51. A.O. Chua, R. Chizzonite, B.B. Desai, T.P. Truitt, P. Nunes, and L.J. Minetti Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130 J Immunol 53(1 1994 128 136 [Epub 1994/07/01]
52. A.O. Chua, V.L. Wilkinson, D.H. Presky, and U. Gubler Cloning and characterization of a mouse IL-12 receptor-beta component J Immunol 155 9 1995 4286 4294 [Epub 1995/11/01]
53. U. Gubler, and D.H. Presky Molecular biology of interleukin-12 receptors Ann N Y Acad Sci 795 1996 36 40 [Epub 1996/10/31]
54. G.X. Zhang, S. Yu, B. Gran, J. Li, I. Siglienti, and X. Chen Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis J Immunol 171 9 2003 4485 4492 [Epub 2003/10/22]
55. C. Parham, M. Chirica, J. Timans, E. Vaisberg, M. Travis, and J. Cheung A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R J Immunol 168 11 2002 5699 5708 [Epub 2002/05/23]
56. B.G. Xiao, C.G. Ma, L.Y. Xu, H. Link, and C.Z. Lu IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis Mol Immunol 45 4 2008 1191 1196 [Epub 2007/08/19]
57. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, and B. Seymour Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 6924 2003 744 748 [Epub 2003/03/01]
58. B. Oppmann, R. Lesley, B. Blom, J.C. Timans, Y. Xu, and B. Hunte Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 5 2000 715 725 [Epub 2000/12/15]
59. F. Gerosa, B. Baldani-Guerra, L.A. Lyakh, G. Batoni, S. Esin, and R.T. Winkler-Pickett Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells J Exp Med 205 6 2008 1447 1461 [Epub 2008/05/21]
60. L. Lyakh, G. Trinchieri, L. Provezza, G. Carra, and F. Gerosa Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans Immunol Rev 226 2008 112 131 [Epub 2009/01/24]
61. D.C. Fitzgerald, B. Ciric, T. Touil, H. Harle, J. Grammatikopolou, and J. Das Sarma Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis J Immunol 179 5 2007 3268 3275
62. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, and K.M. Murphy Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 11 2005 1123 1132 [Epub 2005/10/04]
63. H. Park, Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, and Y.H. Wang A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 11 2005 1133 1141 [Epub 2005/10/04]
64. Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, and S. Kakuta IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis J Immunol 177 1 2006 566 573 [Epub 2006/06/21]
65. S. Haak, A.L. Croxford, K. Kreymborg, F.L. Heppner, S. Pouly, and B. Becher IL-17A and IL-17 F do not contribute vitally to autoimmune neuro-inflammation in mice J Clin Invest 119 1 2009 61 69 [Epub 2008/12/17]
66. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, and J.D. Sedgwick IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2 2005 233 240 [Epub 2005/01/20]
67. M.A. Kroenke, T.J. Carlson, A.V. Andjelkovic, and B.M. Segal IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition J Exp Med 205 7 2008 1535 1541 [Epub 2008/06/25]
68. J.T. Tigno-Aranjuez, R. Jaini, V.K. Tuohy, P.V. Lehmann, and M. Tary-Lehmann Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells J Immunol 183 9 2009 5654 5661 [Epub 2009/10/09]
69. Y. Chen, C.L. Langrish, B. McKenzie, B. Joyce-Shaikh, J.S. Stumhofer, and T. McClanahan Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis J Clin Invest 116 5 2006 1317 1326 [Epub 2006/05/04]
70. C. Uyttenhove, and J. Van Snick Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis Eur J Immunol 36 11 2006 2868 2874 [Epub 2006/10/19]
71. A.W. Burgess, and D. Metcalf The nature and action of granulocyte-macrophage colony stimulating factors Blood 56 6 1980 947 958 [Epub 1980/12/01]
72. E.D. Ponomarev, L.P. Shriver, K. Maresz, J. Pedras-Vasconcelos, D. Verthelyi, and B.N. Dittel GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis J Immunol 178 1 2007 39 48
73. M. El-Behi, B. Ciric, H. Dai, Y. Yan, M. Cullimore, and F. Safavi The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF Nat Immunol 12 6 2011 568 575 [Epub 2011/04/26]
74. L. Codarri, G. Gyulveszi, V. Tosevski, L. Hesske, A. Fontana, and L. Magnenat RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation Nat Immunol 12 6 2011 560 567 [Epub 2011/04/26]
75. J.A. Hamilton Coordinate and noncoordinate colony stimulating factor formation by human monocytes J Leukoc Biol 55 3 1994 355 361
76. J.R. Timoshanko, A.R. Kitching, T.J. Semple, S.R. Holdsworth, and P.G. Tipping Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis J Am Soc Nephrol 16 9 2005 2646 2656
77. J.R. Zucali, C.A. Dinarello, D.J. Oblon, M.A. Gross, L. Anderson, and R.S. Weiner Interleukin 1 stimulates fibroblasts to produce granulocyte- macrophage colony-stimulating activity and prostaglandin E2 J Clin Invest 77 6 1986 1857 1863
78. G.C. Bagby Jr., C.A. Dinarello, P. Wallace, C. Wagner, S. Hefeneider, and E. McCall Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells J Clin Invest 78 5 1986 1316 1323
79. T. Leizer, J. Cebon, J.E. Layton, and J.A. Hamilton Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor Blood 76 10 1990 1989 1996
80. I.K. Campbell, U. Novak, J. Cebon, J.E. Layton, and J.A. Hamilton Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1 J Immunol 147 4 1991 1238 1246
81. E.L. Filonzi, H. Zoellner, H. Stanton, and J.A. Hamilton Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells Atherosclerosis 99 2 1993 241 252
82. D.P. Gearing, J.A. King, N.M. Gough, and N.A. Nicola Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor EMBO J 8 12 1989 3667 3676
83. A.D. Whetton, and T.M. Dexter Myeloid haemopoietic growth factors Biochim Biophys Acta 989 2 1989 111 132
84. D. Metcalf Hematopoietic regulators: redundancy or subtlety? Blood 82 12 1993 3515 3523
85. T. Kitamura, N. Sato, K. Arai, and A. Miyajima Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors Cell 66 6 1991 1165 1174
86. J. Tavernier, R. Devos, S. Cornelis, T. Tuypens, J. Van der Heyden, and W. Fiers A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF Cell 66 6 1991 1175 1184
87. T.R. Hercus, D. Thomas, M.A. Guthridge, P.G. Ekert, J. King-Scott, and M.W. Parker The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease Blood 114 7 2009 1289 1298
88. G.E. Hancock, G. Kaplan, and Z.A. Cohn Keratinocyte growth regulation by the products of immune cells J Exp Med 168 4 1988 1395 1402
89. R. Soldi, L. Primo, M.F. Brizzi, F. Sanavio, M. Aglietta, and N. Polentarutti Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor Blood 89 3 1997 863 872
90. J.K. Choi, B.H. Choi, Y. Ha, H. Park, S.H. Yoon, and H.C. Park Signal transduction pathways of GM-CSF in neural cell lines Neurosci Lett 420 3 2007 217 222
91. G.C. Baldwin, J.C. Gasson, S.E. Kaufman, S.G. Quan, R.E. Williams, and B.R. Avalos Nonhematopoietic tumor cells express functional GM-CSF receptors Blood 73 4 1989 1033 1037
92. S. Dedhar, L. Gaboury, P. Galloway, and C. Eaves Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin Proc Natl Acad Sci U S A 85 23 1988 9253 9257
93. F. Bussolino, J.M. Wang, P. Defilippi, F. Turrini, F. Sanavio, and C.J. Edgell Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate Nature 337 6206 1989 471 473
94. F. Bussolino, M. Ziche, J.M. Wang, D. Alessi, L. Morbidelli, and O. Cremona In vitro and in vivo activation of endothelial cells by colony-stimulating factors J Clin Invest 87 3 1991 986 995
95. C.I. Rivas, J.C. Vera, F. Delgado-Lopez, M.L. Heaney, V.H. Guaiquil, and R.H. Zhang Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer Blood 91 3 1998 1037 1043
96. S. Bozinovski, J.E. Jones, R. Vlahos, J.A. Hamilton, and G.P. Anderson Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo J Biol Chem 277 45 2002 42808 42814
97. S. Bozinovski, J. Jones, S.J. Beavitt, A.D. Cook, J.A. Hamilton, and G.P. Anderson Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4 Am J Physiol Lung Cell Mol Physiol 286 4 2004 L877 L885
98. A.J. Fleetwood, A.D. Cook, and J.A. Hamilton Functions of granulocyte-macrophage colony-stimulating factor Crit Rev Immunol 25 5 2005 405 428
99. E.R. Stanley, D.M. Chen, and H.S. Lin Induction of macrophage production and proliferation by a purified colony stimulating factor Nature 274 5667 1978 168 170
100. E.R. Stanley, K.L. Berg, D.B. Einstein, P.S. Lee, F.J. Pixley, and Y. Wang Biology and action of colony-stimulating factor-1 Mol Reprod Dev 46 1 1997 4 10
101. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, and M. Kearney Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat Med 5 4 1999 434 438
102. J.A. Hamilton Colony-stimulating factors in inflammation and autoimmunity Nat Rev Immunol 8 7 2008 533 544
103. I.K. Campbell, M.J. Rich, R.J. Bischof, A.R. Dunn, D. Grail, and J.A. Hamilton Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice J Immunol 161 7 1998 3639 3644
104. A.D. Cook, E.L. Braine, I.K. Campbell, M.J. Rich, and J.A. Hamilton Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease Arthritis Res 3 5 2001 293 298
105. J.L. McQualter, R. Darwiche, C. Ewing, M. Onuki, T.W. Kay, and J.A. Hamilton Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis J Exp Med 194 7 2001 873 882
106. A.R. Kitching, X. Ru Huang, A.L. Turner, P.G. Tipping, A.R. Dunn, and S.R. Holdsworth The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury J Am Soc Nephrol 13 2 2002 350 358
107. E.C. Cates, R. Fattouh, J. Wattie, M.D. Inman, S. Goncharova, and A.J. Coyle Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism J Immunol 173 10 2004 6384 6392
108. R. Vlahos, S. Bozinovski, J.A. Hamilton, and G.P. Anderson Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF) Pharmacol Ther 112 1 2006 106 115
109. N. Yamashita, H. Tashimo, H. Ishida, F. Kaneko, J. Nakano, and H. Kato Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF) Cell Immunol 219 2 2002 92 97
110. M. Ditiatkovski, B.H. Toh, and A. Bobik GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice Arterioscler Thromb Vasc Biol 26 10 2006 2337 2344
111. J. Shindo, T. Ishibashi, K. Yokoyama, K. Nakazato, T. Ohwada, and M. Shiomi Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits Circulation 99 16 1999 2150 2156
112. J.O. Armitage Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor Blood 92 12 1998 4491 4508
113. J.A. Reed, D.J. Clegg, K.B. Smith, E.G. Tolod-Richer, E.K. Matter, and L.S. Picard GM-CSF action in the CNS decreases food intake and body weight J Clin Invest 115 11 2005 3035 3044
114. S. Gaudreau, C. Guindi, M. Menard, G. Besin, G. Dupuis, and A. Amrani Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4 + CD25 + regulatory T cells J Immunol 179 6 2007 3638 3647
115. M.J. McGeachy, K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, and T. McClanahan TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology Nat Immunol 8 12 2007 1390 1397 [Epub 2007/11/13]
116. S. Pflanz, J.C. Timans, J. Cheung, R. Rosales, H. Kanzler, and J. Gilbert IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells Immunity 16 6 2002 779 790 [Epub 2002/07/18]
117. S. Pflanz, L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, and J.F. Bazan WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 J Immunol 172 4 2004 2225 2231 [Epub 2004/02/07]
118. A.V. Villarino, E. Huang, and C.A. Hunter Understanding the pro- and anti-inflammatory properties of IL-27 J Immunol 173 2 2004 715 720 [Epub 2004/07/09]
119. A. Takeda, S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, and T.W. Mak Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment J Immunol 170 10 2003 4886 4890 [Epub 2003/05/08]
120. M. Batten, J. Li, S. Yi, N.M. Kljavin, D.M. Danilenko, and S. Lucas Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nat Immunol 7 9 2006 929 936
121. J.S. Stumhofer, A. Laurence, E.H. Wilson, E. Huang, C.M. Tato, and L.M. Johnson Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system Nat Immunol 7 9 2006 937 945 [Epub 2006/08/15]
122. I.I. Ivanov, L. Zhou, and D.R. Littman Transcriptional regulation of Th17 cell differentiation Semin Immunol 19 6 2007 409 417
123. T. Yoshimoto, T. Yoshimoto, K. Yasuda, J. Mizuguchi, and K. Nakanishi IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation J Immunol 179 7 2007 4415 4423
124. M. Huber, V. Steinwald, A. Guralnik, A. Brustle, P. Kleemann, and C. Rosenplanter IL-27 inhibits the development of regulatory T cells via STAT3 Int Immunol 20 2 2008 223 234
125. S. Wang, Y. Miyazaki, Y. Shinozaki, and H. Yoshida Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency J Immunol 179 10 2007 6421 6428
126. B. Guo, E.Y. Chang, and G. Cheng The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice J Clin Invest 118 5 2008 1680 1690
127. Y. Miyazaki, Y. Shimanoe, S. Wang, and H. Yoshida Amelioration of delayed-type hypersensitivity responses by IL-27 administration Biochem Biophys Res Commun 373 3 2008 397 402
128. Y. Cao, P.D. Doodes, T.T. Glant, and A. Finnegan IL-27 induces a Th1 immune response and susceptibility to experimental arthritis J Immunol 180 2 2008 922 930
129. N. Sugiyama, H. Nakashima, T. Yoshimura, A. Sadanaga, S. Shimizu, and K. Masutani Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of IL-27R{alpha} (WSX-1) Ann Rheum Dis 67 10 Oct 2008 1461 1467
130. A. Young, E. Linehan, E. Hams, A.C. O'Hara Hall, A. McClurg, and J.A. Johnston Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27 J Immunol 189 5 2012 2079 2083 [Epub 2012/07/28]
131. M. El-behi, B. Ciric, S. Yu, G.X. Zhang, D.C. Fitzgerald, and A. Rostami Differential effect of IL-27 on developing versus committed Th17 cells J Immunol 183 8 2009 4957 4967 [Epub 2009/09/30]
132. M. Veldhoen, C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, and J. Buer Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset Nat Immunol 9 12 2008 1341 1346 [Epub 2008/10/22]
133. V. Dardalhon, A. Awasthi, H. Kwon, G. Galileos, W. Gao, and R.A. Sobel IL-4 inhibits TGF-beta-induced Foxp3 + T cells and, together with TGF-beta, generates IL-9 + IL-10 + Foxp3(-) effector T cells Nat Immunol 9 12 2008 1347 1355 [Epub 2008/11/11]
134. C. Tan, and I. Gery The unique features of Th9 cells and their products Crit Rev Immunol 32 1 2012 1 10 [Epub 2012/03/21]
135. R. Jabeen, and M.H. Kaplan The symphony of the ninth: the development and function of Th9 cells Curr Opin Immunol 24 3 2012 303 307 [Epub 2012/03/01]
136. M. Stassen, E. Schmitt, and T. Bopp From interleukin-9 to T helper 9 cells Ann N Y Acad Sci 1247 2012 56 68 [Epub 2012/01/13]
137. C. Wilhelm, K. Hirota, B. Stieglitz, J. Van Snick, M. Tolaini, and K. Lahl An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation Nat Immunol 12 11 2011 1071 1077 [Epub 2011/10/11]
138. E.C. Nowak, and R.J. Noelle Interleukin-9 as a T helper type 17 cytokine Immunology 131 2 2010 169 173 [Epub 2010/08/03]
139. H. Li, and A. Rostami IL-9: basic biology, signaling pathways in CD4 + T cells and implications for autoimmunity J Neuroimmune Pharmacol 5 2 2010 198 209 [Epub 2009/12/19]
140. L. Hultner, C. Druez, J. Moeller, C. Uyttenhove, E. Schmitt, and E. Rude Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9) Eur J Immunol 20 6 1990 1413 1416
141. C. Uyttenhove, R.J. Simpson, and J. Van Snick Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity Proc Natl Acad Sci U S A 85 18 1988 6934 6938
142. W. Elyaman, E.M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, and J. Imitola IL-9 induces differentiation of TH17 cells and enhances function of FoxP3 + natural regulatory T cells Proc Natl Acad Sci U S A 106 31 2009 12885 12890 [Epub 2009/05/13]
143. W. Elyaman, R. Bassil, E.M. Bradshaw, W. Orent, Y. Lahoud, and B. Zhu Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells Immunity 36 4 2012 623 634 [Epub 2012/04/17]
144. E.C. Nowak, C.T. Weaver, H. Turner, S. Begum-Haque, B. Becher, and B. Schreiner IL-9 as a mediator of Th17-driven inflammatory disease J Exp Med 206 8 2009 1653 1660 [Epub 2009/07/15]
145. H. Li, B. Nourbakhsh, B. Ciric, G.X. Zhang, and A. Rostami Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population J Immunol 185 7 2010 4095 4100 [Epub 2010/09/02]
146. H. Li, B. Nourbakhsh, M. Cullimore, G.X. Zhang, and A. Rostami IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system Eur J Immunol 41 8 2011 2197 2206 [Epub 2011/06/16]
147. G. Murugaiyan, V. Beynon, A. Pires Da Cunha, N. Joller, and H.L. Weiner IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27 J Immunol 189 11 2012 5277 5283 [Epub 2012/11/06]
148. Y. Zhou, Y. Sonobe, T. Akahori, S. Jin, J. Kawanokuchi, and M. Noda IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes J Immunol 186 7 2011 4415 4421 [Epub 2011/02/25]
149. Y. Lu, S. Hong, H. Li, J. Park, B. Hong, and L. Wang Th9 cells promote antitumor immune responses in vivo J Clin Invest 122 11 2012 4160 4171 [Epub 2012/10/16]
150. A. Jager, V. Dardalhon, R.A. Sobel, E. Bettelli, and V.K. Kuchroo Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes J Immunol 183 11 2009 7169 7177 [Epub 2009/11/06]
151. C. Tan, M.K. Aziz, J.D. Lovaas, B.P. Vistica, G. Shi, and E.F. Wawrousek Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site J Immunol 185 11 2010 6795 6801 [Epub 2010/10/26]
152. K. Hirota, J.H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, and D.J. Cua Fate mapping of IL-17-producing T cells in inflammatory responses Nat Immunol 12 3 2011 255 263 [Epub 2011/02/01]
153. J.S. Tzartos, M.A. Friese, M.J. Craner, J. Palace, J. Newcombe, and M.M. Esiri Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis Am J Pathol 172 1 2008 146 155 [Epub 2007/12/25]
154. A. Uzawa, M. Mori, K. Arai, Y. Sato, S. Hayakawa, and S. Masuda Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6 Mult Scler 16 12 2010 1443 1452
155. C. Benoist, and D. Mathis Treg cells, life history, and diversity Cold Spring Harb Perspect Biol 4 9 2012 a007021 [Epub 2012/09/07]
156. H.J. Kim, and H. Cantor Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells Semin Immunol 23 6 2011 446 452 [Epub 2011/12/06]
157. C. Mauri, and A. Bosma Immune regulatory function of B cells Annu Rev Immunol 30 2012 221 241 [Epub 2012/01/10]
158. D. Lindau, P. Gielen, M. Kroesen, P. Wesseling, and G.J. Adema The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells Immunology 138 2 2013 105 115 [Epub 2012/12/12]
159. D.E. Lowther, and D.A. Hafler Regulatory T cells in the central nervous system Immunol Rev 248 1 2012 156 169 [Epub 2012/06/26]
160. T.L. Geiger, and S. Tauro Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function Hum Immunol 73 3 2012 232 239 [Epub 2012/01/14]
161. L.W. Collison, V. Chaturvedi, A.L. Henderson, P.R. Giacomin, C. Guy, and J. Bankoti IL-35-mediated induction of a potent regulatory T cell population Nat Immunol 11 12 2010 1093 1101 [Epub 2010/10/19]
162. S.Z. Josefowicz, L.F. Lu, and A.Y. Rudensky Regulatory T cells: mechanisms of differentiation and function Annu Rev Immunol 30 2012 531 564 [Epub 2012/01/10]
163. V. Kumar, and E.E. Sercarz The involvement of T cell receptor peptide-specific regulatory CD4 + T cells in recovery from antigen-induced autoimmune disease J Exp Med 178 3 1993 909 916 [Epub 1993/09/01]
164. J.J. Lafaille, K. Nagashima, M. Katsuki, and S. Tonegawa High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice Cell 78 3 1994 399 408 [Epub 1994/08/12]
165. D. Olivares-Villagomez, Y. Wang, and J.J. Lafaille Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis J Exp Med 188 10 1998 1883 1894 [Epub 1998/11/17]
166. A.P. Kohm, P.A. Carpentier, H.A. Anger, and S.D. Miller Cutting edge: CD4 + CD25 + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis J Immunol 169 9 2002 4712 4716 [Epub 2002/10/23]
167. J. Reddy, Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, and L. Nicholson Myelin proteolipid protein-specific CD4 + CD25 + regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis Proc Natl Acad Sci U S A 101 43 2004 15434 15439 [Epub 2004/10/20]
168. T. Korn, E. Bettelli, W. Gao, A. Awasthi, A. Jager, and T.B. Strom IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells Nature 448 7152 2007 484 487 [Epub 2007/06/22]
169. L.A. Stephens, D. Gray, and S.M. Anderton CD4 + CD25 + regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity Proc Natl Acad Sci U S A 102 48 2005 17418 17423 [Epub 2005/11/17]
170. X. Zhang, D.N. Koldzic, L. Izikson, J. Reddy, R.F. Nazareno, and S. Sakaguchi IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25 + CD4 + regulatory T cells Int Immunol 16 2 2004 249 256 [Epub 2004/01/22]
171. E. Montero, G. Nussbaum, J.F. Kaye, R. Perez, A. Lage, and A. Ben-Nun Regulation of experimental autoimmune encephalomyelitis by CD4 +, CD25 + and CD8 + T cells: analysis using depleting antibodies J Autoimmun 23 1 2004 1 7 [Epub 2004/07/09]
172. Y. Liu, I. Teige, B. Birnir, and S. Issazadeh-Navikas Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE Nat Med 12 5 2006 518 525 [Epub 2006/04/25]
173. T. Korn, J. Reddy, W. Gao, E. Bettelli, A. Awasthi, and T.R. Petersen Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation Nat Med 13 4 2007 423 431 [Epub 2007/03/27]
174. M.J. McGeachy, L.A. Stephens, and S.M. Anderton Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25 + regulatory cells within the central nervous system J Immunol 175 5 2005 3025 3032 [Epub 2005/08/24]
175. R.A. O'Connor, K.H. Malpass, and S.M. Anderton The inflamed central nervous system drives the activation and rapid proliferation of Foxp3 + regulatory T cells J Immunol 179 2 2007 958 966 [Epub 2007/07/10]
176. V. Trajkovic, O. Vuckovic, S. Stosic-Grujicic, D. Miljkovic, D. Popadic, and M. Markovic Astrocyte-induced regulatory T cells mitigate CNS autoimmunity Glia 47 2 2004 168 179 [Epub 2004/06/09]
177. V. Viglietta, C. Baecher-Allan, H.L. Weiner, and D.A. Hafler Loss of functional suppression by CD4 + CD25 + regulatory T cells in patients with multiple sclerosis J Exp Med 199 7 2004 971 979 [Epub 2004/04/07]
178. U. Feger, C. Luther, S. Poeschel, A. Melms, E. Tolosa, and H. Wiendl Increased frequency of CD4 + CD25 + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients Clin Exp Immunol 147 3 2007 412 418 [Epub 2007/02/17]
179. G. Frisullo, V. Nociti, R. Iorio, A.K. Patanella, M. Caggiula, and A. Marti Regulatory T cells fail to suppress CD4T + - bet + T cells in relapsing multiple sclerosis patients Immunology 127 3 2009 418 428 [Epub 2008/11/20]
180. J. Haas, A. Hug, A. Viehover, B. Fritzsching, C.S. Falk, and A. Filser Reduced suppressive effect of CD4 + CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis Eur J Immunol 35 11 2005 3343 3352 [Epub 2005/10/06]
181. K. Venken, N. Hellings, T. Broekmans, K. Hensen, J.L. Rummens, and P. Stinissen Natural naive CD4 + CD25 + CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression J Immunol 180 9 2008 6411 6420 [Epub 2008/04/22]
182. K. Venken, N. Hellings, M. Thewissen, V. Somers, K. Hensen, and J.L. Rummens Compromised CD4 + CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level Immunology 123 1 2008 79 89 [Epub 2007/09/28]
183. J. Huan, N. Culbertson, L. Spencer, R. Bartholomew, G.G. Burrows, and Y.K. Chou Decreased FOXP3 levels in multiple sclerosis patients J Neurosci Res 81 1 2005 45 52 [Epub 2005/06/14]
184. K. Venken, N. Hellings, K. Hensen, J.L. Rummens, R. Medaer, and M.B. D'Hooghe Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4 + CD25 + regulatory T-cell function and FOXP3 expression J Neurosci Res 83 8 2006 1432 1446 [Epub 2006/04/04]
185. C. de Andres, C. Aristimuno, V. de Las Heras, M.L. Martinez-Gines, M. Bartolome, and R. Arroyo Interferon beta-1a therapy enhances CD4 + regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis J Neuroimmunol 182 1,2 2007 204 211
186. M. Korporal, J. Haas, B. Balint, B. Fritzsching, A. Schwarz, and S. Moeller Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells Arch Neurol 65 11 2008 1434 1439 [Epub 2008/11/13]
187. J. Hong, N. Li, X. Zhang, B. Zheng, and J.Z. Zhang Induction of CD4 + CD25 + regulatory T cells by copolymer-I through activation of transcription factor Foxp3 Proc Natl Acad Sci U S A 102 18 2005 6449 6454 [Epub 2005/04/27]
188. S.R. Carding, and P.J. Egan Gammadelta T cells: functional plasticity and heterogeneity Nat Rev Immunol 2 5 2002 336 345 [Epub 2002/05/30]
189. J.M. Lewis, M. Girardi, S.J. Roberts, S.D. Barbee, A.C. Hayday, and R.E. Tigelaar Selection of the cutaneous intraepithelial gammadelta + T cell repertoire by a thymic stromal determinant Nat Immunol 7 8 2006 843 850 [Epub 2006/07/11]
190. M. Bigby, J.S. Markowitz, P.A. Bleicher, M.J. Grusby, S. Simha, and M. Siebrecht Most gamma delta T cells develop normally in the absence of MHC class II molecules J Immunol 15 9 1993 4465 4475 [Epub 1993/11/01]
191. I. Correa, M. Bix, N.S. Liao, M. Zijlstra, R. Jaenisch, and D. Raulet Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice Proc Natl Acad Sci U S A 89 2 1992 653 657 [Epub 1992/01/15]
192. N. Duhindan, A.J. Farley, S. Humphreys, C. Parker, B. Rossiter, and C.G. Brooks Patterns of lymphokine secretion amongst mouse gamma delta T cell clones Eur J Immunol 27 7 1997 1704 1712 [Epub 1997/07/01]
193. K.A. Rhodes, E.M. Andrew, D.J. Newton, D. Tramonti, and S.R. Carding A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury Eur J Immunol 38 8 2008 2274 2283 [Epub 2008/07/16]
194. K.D. Jensen, X. Su, S. Shin, L. Li, S. Youssef, and S. Yamasaki Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma Immunity 29 1 2008 90 100 [Epub 2008/07/01]
195. J.R. Lukens, M.J. Barr, D.D. Chaplin, H. Chi, and T.D. Kanneganti Inflammasome-derived IL-1beta regulates the production of GM-CSF by CD4(+) T cells and gammadelta T cells J Immunol 188 7 2012 3107 3115 [Epub 2012/02/22]
196. B. Martin, K. Hirota, D.J. Cua, B. Stockinger, and M. Veldhoen Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals Immunity 31 2 2009 321 330 [Epub 2009/08/18]
197. J.C. Ribot, A. deBarros, D.J. Pang, J.F. Neves, V. Peperzak, and S.J. Roberts CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets Nat Immunol 10 4 2009 427 436 [Epub 2009/03/10]
198. Y. Kobayashi, K. Kawai, K. Ito, H. Honda, G. Sobue, and Y. Yoshikai Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody J Neuroimmunol 73 1,2 1997 169 174 [Epub 1997/03/01]
199. E.D. Ponomarev, M. Novikova, M. Yassai, M. Szczepanik, J. Gorski, and B.N. Dittel Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis J Immunol 173 3 2004 1587 1595 [Epub 2004/07/22]
200. E.D. Ponomarev, and B.N. Dittel Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism J Immunol 174 8 2005 4678 4687 [Epub 2005/04/09]
201. R.B. Clark, and E.G. Lingenheld Adoptively transferred EAE in gamma delta T cell-knockout mice J Autoimmun 11 1 1998 105 110 [Epub 1998/03/14]
202. A.J. Rajan, Y.L. Gao, C.S. Raine, and C.F. Brosnan A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse J Immunol 157 2 1996 941 949
203. A.J. Rajan, J.D. Klein, and C.F. Brosnan The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis J Immunol 160 12 1998 5955 5962 [Epub 1998/06/24]
204. T.W. Spahn, S. Issazadah, A.J. Salvin, and H.L. Weiner Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene Eur J Immunol 29 12 1999 4060 4071 [Epub 1999/12/22]
205. C.E. Sutton, S.J. Lalor, C.M. Sweeney, C.F. Brereton, E.C. Lavelle, and K.H. Mills Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity Immunity 3 2 2009 331 341
206. F. Petermann, V. Rothhammer, M.C. Claussen, J.D. Haas, L.R. Blanco, and S. Heink Gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism Immunity 33 3 2010 351 363 [Epub 2010/09/14]
207. T. Ishizu, M. Osoegawa, F.J. Mei, H. Kikuchi, M. Tanaka, and Y. Takakura Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis Brain 128 Pt 5 2005 988 1002 [Epub 2005/03/04]